|
GB8709871D0
(en)
*
|
1987-04-27 |
1987-06-03 |
Turner R C |
Peptides
|
|
AU634716B2
(en)
|
1988-08-01 |
1993-03-04 |
Ciba Corning Diagnostics Corp. |
Method for detection of an analyte using acridinium esters and liposomes
|
|
US5430047A
(en)
*
|
1994-04-07 |
1995-07-04 |
Warner-Lambert Company |
Neurotensin antagonists
|
|
WO1995033474A1
(en)
*
|
1994-06-03 |
1995-12-14 |
Tsumura & Co. |
Medicinal composition
|
|
JP4394279B2
(ja)
*
|
1998-03-09 |
2010-01-06 |
ジーランド ファーマ アクティーゼルスカブ |
酵素加水分解に対する傾向が減少した薬理学的に活性なペプチド複合体
|
|
US6248527B1
(en)
*
|
1998-10-21 |
2001-06-19 |
Millennium Pharmaceuticals, Inc. |
Method of detecting risk of type II diabetes based on mutations found in carboxypeptidase E
|
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
|
IL142707A0
(en)
*
|
2000-04-27 |
2002-03-10 |
Pfizer Prod Inc |
Methods of treating obesity using a neurotensin receptor ligand
|
|
US7271153B2
(en)
*
|
2001-06-20 |
2007-09-18 |
Kissei Pharmaceutical Co., Ltd. |
Nitrogenous heterocyclic derivatives, medicinal compositions containing the same, medicinal uses thereof, and intermediates therefor
|
|
RU2004109222A
(ru)
|
2001-08-30 |
2005-10-20 |
Байорексис Фармасьютикал Корпорейшн (Us) |
Слитые белки модифицированного трансферрина
|
|
WO2003103475A2
(en)
|
2002-06-07 |
2003-12-18 |
Dyax Corp. |
Prevention and reduction of blood loss
|
|
WO2005040229A2
(en)
|
2003-10-24 |
2005-05-06 |
Avidia, Inc. |
Ldl receptor class a and egf domain monomers and multimers
|
|
US20100028995A1
(en)
|
2004-02-23 |
2010-02-04 |
Anaphore, Inc. |
Tetranectin Trimerizing Polypeptides
|
|
US8278262B2
(en)
|
2004-09-21 |
2012-10-02 |
Biontech Ag |
Use of microproteins as tryptase inhibitors
|
|
DE102005003687A1
(de)
*
|
2005-01-26 |
2006-07-27 |
Sphingo Tec Gmbh |
Immunoassay zur Bestimmung der Freisetzung von Neurotensin in die Zirkulation
|
|
WO2006110082A1
(en)
*
|
2005-04-11 |
2006-10-19 |
Astrazeneca Ab |
A method and a kit for diagnosing type 2 diabetes, metabolic syndrome, sub clinical atherosclerosis, myocardial infarct, stroke or clinical manifestations of diabetes.
|
|
US8119358B2
(en)
*
|
2005-10-11 |
2012-02-21 |
Tethys Bioscience, Inc. |
Diabetes-related biomarkers and methods of use thereof
|
|
DK2231860T3
(da)
|
2007-12-19 |
2011-12-05 |
Affibody Ab |
Polypeptid afledt protein A og i stand til at binde PDGF
|
|
EP3785735A1
(en)
|
2008-11-03 |
2021-03-03 |
Molecular Partners AG |
Binding proteins inhibiting the vegf-a receptor interaction
|
|
CA2745524C
(en)
*
|
2008-12-05 |
2020-06-09 |
Angiochem Inc. |
Conjugates of neurotensin or neurotensin analogs and uses thereof
|
|
EP2374003B1
(en)
|
2009-01-07 |
2015-03-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment, the prognostic assessment and the detection of breast cancer
|
|
MX2012002428A
(es)
|
2009-08-27 |
2012-09-12 |
Covagen Ag |
Compuestos de union il-17 y usos medicos de los mismos.
|
|
US9217747B2
(en)
*
|
2009-10-29 |
2015-12-22 |
Health Diagnostic Laboratory, Inc. |
Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes
|
|
AU2010332932B2
(en)
|
2009-12-14 |
2013-01-17 |
Navigo Proteins Gmbh |
Modified ubiquitin proteins having a specific binding activity for the extradomain B of fibronectin
|
|
UA58612U
(uk)
*
|
2010-06-04 |
2011-04-26 |
Высшее Государственное Учебное Заведение «Украинская Медицинская Стоматологическая Академия» |
Спосіб діагностики інсулінорезистентності у хворих на метаболічний синдром та цукровий діабет 2 типу
|
|
RU2569745C2
(ru)
|
2010-06-08 |
2015-11-27 |
Пиерис АГ |
Мутеины липокалина слезы, связывающие альфа il-4 r
|
|
ES2781084T3
(es)
*
|
2015-02-27 |
2020-08-28 |
Sphingotec Gmbh |
Un método para predecir el riesgo de obesidad en un sujeto
|